Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$887M |
| 2 |
Amazon
AMZN
|
+$857M |
| 3 |
Apple
AAPL
|
+$844M |
| 4 |
Microsoft
MSFT
|
+$802M |
| 5 |
Tesla
TSLA
|
+$606M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$760M |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$515M |
| 3 |
WORK
Slack Technologies, Inc.
WORK
|
+$258M |
| 4 |
Oracle
ORCL
|
+$126M |
| 5 |
PFPT
Proofpoint, Inc.
PFPT
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.66% |
| 2 | Financials | 14.07% |
| 3 | Healthcare | 13.55% |
| 4 | Consumer Discretionary | 11.86% |
| 5 | Communication Services | 10.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WEBR
2976
DELISTED
Weber Inc.
WEBR
| $4.42M | ﹤0.01% |
+251,327
| New | +$4.03M |
|
2977
Harvard Bioscience
HBIO
$28.1M
| $4.41M | ﹤0.01% |
63,189
+1,793
| +3% | +$143K |
|
|
FXLV
2978
DELISTED
F45 Training Holdings Inc.
FXLV
| $4.41M | ﹤0.01% |
+294,685
| New | +$4.32M |
|
|
MTEM
2979
DELISTED
Molecular Templates, Inc.
MTEM
| $4.41M | ﹤0.01% |
43,794
-1,942
| -4% | -$200K |
|
2980
The Beachbody Company
BODI
$46.6M
| $4.4M | ﹤0.01% |
+15,900
| New | +$6.36M |
|
2981
Kinetik
KNTK
$4.12B
| $4.4M | ﹤0.01% |
127,406
+10,618
| +9% | +$349K |
|
|
TBHC
2982
DELISTED
The Brand House Collective
TBHC
| $4.4M | ﹤0.01% |
228,879
+1,635
| +0.7% | +$32.3K |
|
|
SMMF
2983
DELISTED
Summit Financial Group, Inc.
SMMF
| $4.39M | ﹤0.01% |
179,319
+3,188
| +2% | +$74.5K |
|
|
EWCZ
2984
DELISTED
European Wax Center
EWCZ
| $4.39M | ﹤0.01% |
+156,770
| New | +$3.92M |
|
2985
Fortress Biotech
FBIO
$91.4M
| $4.38M | ﹤0.01% |
90,745
+3,159
| +4% | +$154K |
|
2986
Evolus
EOLS
$536M
| $4.38M | ﹤0.01% |
574,437
+6,828
| +1% | +$70.6K |
|
|
PVBC
2987
DELISTED
Provident Bancorp
PVBC
| $4.38M | ﹤0.01% |
273,219
+1,413
| +0.5% | +$22.8K |
|
2988
Bolt Biotherapeutics
BOLT
$6.63M
| $4.37M | ﹤0.01% |
17,256
+6,748
| +64% | +$1.91M |
|
2989
Monte Rosa Therapeutics
GLUE
$1.36B
| $4.36M | ﹤0.01% |
+195,783
| New | +$5.61M |
|
2990
Superior Group of Companies
SGC
$213M
| $4.35M | ﹤0.01% |
186,854
+1,730
| +0.9% | +$40.7K |
|
2991
Tilray
TLRY
$640M
| $4.35M | ﹤0.01% |
38,533
+17,557
| +84% | +$2.41M |
|
2992
iBio
IBIO
$69.5M
| $4.35M | ﹤0.01% |
8,202
+1,057
| +15% | +$658K |
|
|
AKUS
2993
DELISTED
Akouos Inc
AKUS
| $4.34M | ﹤0.01% |
374,008
+30,085
| +9% | +$361K |
|
2994
Park Aerospace
PKE
$828M
| $4.34M | ﹤0.01% |
317,186
+3,957
| +1% | +$58K |
|
2995
Citius Pharmaceuticals
CTXR
$20.1M
| $4.33M | ﹤0.01% |
85,245
+9,025
| +12% | +$453K |
|
2996
Radiant Logistics
RLGT
$400M
| $4.32M | ﹤0.01% |
676,234
-1,532
| -0.2% | -$9.86K |
|
2997
Mid Penn Bancorp
MPB
$969M
| $4.3M | ﹤0.01% |
155,961
+3,846
| +3% | +$103K |
|
|
ITIC
2998
Investors Title Co
ITIC
$530M
| $4.29M | ﹤0.01% |
23,519
+480
| +2% | +$86.5K |
|
|
MLNK
2999
DELISTED
MeridianLink
MLNK
| $4.29M | ﹤0.01% |
+191,891
| New | +$4.74M |
|
|
EMKR
3000
DELISTED
Emcore Corp
EMKR
| $4.28M | ﹤0.01% |
57,187
+604
| +1% | +$48.3K |
|
Similar funds
Geode Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Geode Capital Management held 4,944 positions worth $743B, up 2.3% from $726B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geode Capital Management's Q3 2021 filing shows 223 new, 2,961 increased, 1,210 reduced and 86 closed positions. Its largest new stake was Lucid Motors: 565,353 shares worth $143M. The largest sale was Alexion Pharmaceuticals, an estimated $760M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q3 2021 buy was Lucid Motors: 565,353 shares worth $143M.
- Geode Capital Management added most to Moderna in Q3 2021, an estimated $887M increase.
- Geode Capital Management's biggest Q3 2021 reduction was Oracle, cutting an estimated $126M.
- Geode Capital Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $760M.
- Geode Capital Management's ten largest holdings make up 23% of its $743B portfolio in Q3 2021.
- Geode Capital Management opened 223 new positions and closed 86 in Q3 2021.
- Geode Capital Management's portfolio value rose 2.3% quarter-over-quarter to $743B.
Based on Geode Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.